NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks side effects of leading lung cancer therapies
Knowledge-focused OngoingThis study observes 300 adults with advanced non-small cell lung cancer whose tumors have very low PD-L1 levels (below 1%). Researchers are tracking side effects and healthcare use from common first-line treatments like nivolumab plus ipilimumab, with or without chemotherapy. The…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:37 UTC
-
Can muscle strength predict lung cancer treatment success?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 160 people with lung cancer to see how their muscle mass, strength, and function change during treatment. Researchers want to know if these factors affect how well patients tolerate therapy, their quality of life, and overall survival. The goal is to find bette…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC